Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Tumori|October 31, 1989
Evidence for altered hypothalamic-hypophyseal-gonadal axis in untreated patients with testicular germ-cell tumorS Crispino, G Tancini, S Barni, et al.
The International Journal of Biological Markers|January 1, 1989
Prolactin secretion in testicular cancer patientsP Lissoni, S Crispino, S Barni, et al.
Tumori|January 1, 1973
[Response and survival after sequential chemotherapy in Hodgkin's disease]S Monfardini, G Tancini, M Gasparini, et al.
Oncology|January 1, 1991
Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary reportP Lissoni, S Barni, F Rovelli, et al.
Lancet (London, England)|May 21, 1983
Adjuvant chemotherapy in breast cancerG Bonadonna, A Rossi, G Tancini, et al.
Oncology Reports|May 19, 2011
Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomasP Lissoni, S Barni, A Ardizzoia, et al.
Annual Review of Medicine|January 1, 1978
Chemotherapy in prevention of the recurrence of resectable cancerG Bonadonna, G Tancini, A Rossi, et al.
The International Journal of Biological Markers|January 1, 1995
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patientsP Lissoni, S Barni, M G Grassi, et al.
Tumori|December 31, 1979
Treatment of advanced breast cancer with norethisterone acetateM Varini, G Tancini, M Mauri, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Estrogen-receptor status and response to chemotherapy in early and advanced breast cancerG Bonadonna, P Valagussa, G Tancini, et al.
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Tumori|October 31, 1989
Evidence for altered hypothalamic-hypophyseal-gonadal axis in untreated patients with testicular germ-cell tumorS Crispino, G Tancini, S Barni, et al.
The International Journal of Biological Markers|January 1, 1989
Prolactin secretion in testicular cancer patientsP Lissoni, S Crispino, S Barni, et al.
Tumori|January 1, 1973
[Response and survival after sequential chemotherapy in Hodgkin's disease]S Monfardini, G Tancini, M Gasparini, et al.
Oncology|January 1, 1991
Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary reportP Lissoni, S Barni, F Rovelli, et al.
Lancet (London, England)|May 21, 1983
Adjuvant chemotherapy in breast cancerG Bonadonna, A Rossi, G Tancini, et al.
Oncology Reports|May 19, 2011
Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomasP Lissoni, S Barni, A Ardizzoia, et al.
Annual Review of Medicine|January 1, 1978
Chemotherapy in prevention of the recurrence of resectable cancerG Bonadonna, G Tancini, A Rossi, et al.
The International Journal of Biological Markers|January 1, 1995
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patientsP Lissoni, S Barni, M G Grassi, et al.
Tumori|December 31, 1979
Treatment of advanced breast cancer with norethisterone acetateM Varini, G Tancini, M Mauri, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Estrogen-receptor status and response to chemotherapy in early and advanced breast cancerG Bonadonna, P Valagussa, G Tancini, et al.
Pageof 22